For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Christopher Grilli Pharm.D., R.Ph.

Objectives

1. Discuss the role of pharmacogenomics in guiding patient therapy and explaining potential medication intolerances.

2. Review a patient case discussing necessary decision points for evaluating medication intolerances and pharmacogenomics.

3. Discuss potential limitations of pharmacogenomics within the primary care.